Human Genome Sciences, Inc. (HGSI) | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
Human Genome Sciences, Inc. (HGSI)

An SI Board Since March 1996

Posts	SubjectMarks	Bans	Symbol
1127	105	0	HGSI

Emcee: Jeffrey Ogbar	Type: Unmoderated

Introduction Market Data Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
102	Anyone who develops based on the Merck "public domain" data runs the	Rocketman	-	3/22/1997
101	Keep in mind that both HGSI and INCY license out genomics to other companies wh	Rocketman	-	3/22/1997
100	Shdu; HGSI has patents on many genes (over 40 were announced recently, I recal	David Bogdanoff	-	3/22/1997
99	U of Washington is also sequencing cDNA of human genome and is making it public	shdu	-	3/22/1997
98	There are many companies doing the same thing as HGSI, and offering the data ba	shdu	-	3/22/1997
97	I was refering to annual profits. I do believe that they will be profitable i	Mary Remington	-	3/22/1997
96	They don't expect profitable quarters on a regular basis though, they are f	Rocketman	-	3/21/1997
95	I recall from HGSI's quarterly report that it made a profit in the 9 m. pe	David Bogdanoff	-	3/21/1997
94	This stock has no earnings and has not yet made a profit. I personally think	Mary Remington	-	3/20/1997
93	Hey Troll, I've kind of told you what I know re: HGSI Think about the fa	Rocketman	-	3/14/1997
92	Dave: At 37/share, what pros & cons. Is this a price in line with our ear	Troll_29	-	3/14/1997
91	Hot off the wire, they've priced it: Friday March 14 10:36 AM EDT Human	Rocketman	-	3/14/1997
90	Hi Bill---Stock has been weak because of 3 million share secondary overhanging	icanpickem	-	3/13/1997
89	I wounder what effect of the latest news of the technology to make a copy of an	Bill Luan	-	3/13/1997
88	Vector 1 and Jerry since this book I just wrote really pertains more to INCY I	Rocketman	-	3/9/1997
87	Thanks for taking the time to put together such a thoughtful and insightful pos	Vector1	-	3/9/1997
86	Very interesting good post. Please hang around and keep us informed. I have bot	jbershad	-	3/8/1997
85	I am very biased towards INCY's strategy. That isn't to say that HGSI&	Rocketman	-	3/8/1997
84	Dave, I'm interested in your views comparing Incyte's stategy vs HGSI.	Vector1	-	3/7/1997
83	I figure it's hard to go wrong playing genomics long. We are in the informa	Rocketman	-	3/7/1997
82	Well, longterm they look good to me, so I started accumulating on this dip. No	John Zwiener	-	3/6/1997
81	And FDA approvals on these things take lots of time and lots of bucks. While t	Rocketman	-	3/6/1997
80	Im saying there are no royalties until the gene-based drugs are okayed by the F	Boyce Burge	-	3/6/1997
79	Are you saying that they will get no interest on drugs developed on their paten	John Zwiener	-	3/5/1997
78	I dont have their balance sheet in front of me, but if they have reached profit	Boyce Burge	-	3/5/1997

Go to reply# or date (mm/dd/yy):